Literature DB >> 12586079

Specific keynote: genome copy number abnormalities in ovarian cancer.

Joe W Gray1, Seiji Suzuki, Wen-Lin Kuo, Daniel Polikoff, Michael Deavers, Karen Smith-McCune, Andrew Berchuck, Dan Pinkel, Donna Albertson, Gordon B Mills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12586079     DOI： 10.1006/gyno.2002.6677

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  9 in total

1.  A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance.

Authors:  Deyin Xing; Sandra Orsulic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-28       Impact factor: 11.205

Review 2.  Wnt signaling in ovarian tumorigenesis.

Authors:  T A Gatcliffe; B J Monk; K Planutis; R F Holcombe
Journal:  Int J Gynecol Cancer       Date:  2007-11-06       Impact factor: 3.437

3.  Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.

Authors:  Manasa Ramakrishna; Louise H Williams; Samantha E Boyle; Jennifer L Bearfoot; Anita Sridhar; Terence P Speed; Kylie L Gorringe; Ian G Campbell
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

4.  Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.

Authors:  David A Engler; Sumeet Gupta; Whitfield B Growdon; Ronny I Drapkin; Mai Nitta; Petra A Sergent; Serena F Allred; Jenny Gross; Michael T Deavers; Wen-Lin Kuo; Beth Y Karlan; Bo R Rueda; Sandra Orsulic; David M Gershenson; Michael J Birrer; Joe W Gray; Gayatry Mohapatra
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

5.  Database of Trypanosoma cruzi repeated genes: 20,000 additional gene variants.

Authors:  Erik Arner; Ellen Kindlund; Daniel Nilsson; Fatima Farzana; Marcela Ferella; Martti T Tammi; Björn Andersson
Journal:  BMC Genomics       Date:  2007-10-26       Impact factor: 3.969

6.  Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities.

Authors:  Lei Li; Huimin Bai; Jiaxin Yang; Dongyan Cao; Keng Shen
Journal:  Oncotarget       Date:  2017-02-28

Review 7.  Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance.

Authors:  Miriam Teeuwssen; Riccardo Fodde
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

8.  Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.

Authors:  Lovisa Osterberg; Kristina Levan; Karolina Partheen; Ulla Delle; Björn Olsson; Karin Sundfeldt; György Horvath
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

9.  Genome-wide DNA copy number profiling and bioinformatics analysis of ovarian cancer reveals key genes and pathways associated with distinct invasive/migratory capabilities.

Authors:  GuiFen Liu; GuanYu Ruan; MeiMei Huang; LiLi Chen; PengMing Sun
Journal:  Aging (Albany NY)       Date:  2020-01-02       Impact factor: 5.682
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.